General Forum, page-971

And on the continuing to commit resources.

I believe it was no accident the "Letter to Shareholders" in the HY started with this :

We believe the clinical trial market will be a significant revenue generator for the Companygoing forward, especially with the impending launch of our Pulse device which provides a full decentralized clinicaltrial solution for our traditional partners such as Bayer, Novartis, AstraZeneca, GSK and others.

Links Pulse device, impending launch, decentralized clinical trials ( prescription clearance on Pulse will enable) and a list of heavy hitting pharma companies. The plan is laid out for all to see..

Then Toni Hofhine has literally just posted these couple of jobs :





APAC Distribution manager ....

Really !
This spend is being authorised for a reason ... Craig & Niall may be many things, but they are not lunatics.